Target deconvolution strategies in drug discovery involve methods to identify the specific biological targets of bioactive compounds. These strategies enhance understanding of drug action, improve lead optimization, and reduce off-target effects. Techniques such as proteomics, affinity-based methods, and computational modeling are commonly employed to unravel complex target interactions, ultimately streamlining the drug development process.